AUGENLÖSUNG

European patent · EP3209331 · In force

Register entry

Publication number
EP3209331
Application number
EP15791036
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 16, 2015
Published
Aug 30, 2017
Granted
Jul 12, 2023
Protection ends at the latest
Oct 15, 2035
Next annual fee due
Oct 31, 2026
IPC classes
A61K 45/06 (2006.01)
A61K 31/5377 (2006.01)
A61K 31/542 (2006.01)
A61K 31/5575 (2006.01)
A61K 9/00 (2006.01)
A61K 47/32 (2006.01)
A61K 47/34 (2017.01)
A61P 27/06 (2006.01)
Priority
IN 2985DE2014 20.10.2014
PCT application
PCT/IB2015/057963 16.10.2015
PCT publication
WO2016/063184 28.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. May 22, 2024

    Change

    Published in Swissreg on 22.05.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Aug 25, 2023

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 25.08.2023

  6. Jul 12, 2023

    Granted

    Published in Swissreg on 12.07.2023

Parties

Holder

Sentiss Pharma Private Limited

Sentiss Research Centre 212 Ashirwad Commercial Complex D-1 Green Park, New Delhi 110016, IN

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

BAHRI, Deepak

New Delhi 110016, IN

SHAH, Mandar V.

New Delhi 110016, IN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.